Related Experiment Video
Updated: Jun 13, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008
Joshua C Herigon1, Adam L Hersh, Jeffrey S Gerber
1Children's Mercy Hospital and Clinics, Section of Infectious Diseases, 2401 Gillham Rd, Kansas City, MO 64108, USA.
Insights
Antibiotic prescribing for pediatric Staphylococcus aureus infections shifted significantly, with clindamycin becoming the most common treatment due to rising MRSA rates. Continuous monitoring of bacterial susceptibility is crucial.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Stewardship
- Clinical Pharmacy
Background:
- Antibiotic management for Staphylococcus aureus (S aureus) infections in children requires understanding evolving resistance patterns.
- The emergence of methicillin-resistant S aureus (MRSA) has altered treatment strategies.
- Trends in pediatric S aureus treatment are not well-characterized.
Purpose of the Study:
- To describe trends in antibiotic management for S aureus infections in hospitalized children.
- To analyze changes in antibiotic use from 1999 to 2008.
Main Methods:
- Retrospective study using the Pediatric Health Information Systems database.
- Included inpatients with S aureus infection codes (1999-2008) at 25 US children's hospitals.
- Examined trends in vancomycin, clindamycin, linezolid, trimethoprim-sulfamethoxazole, cefazolin, and oxacillin/nafcillin use.
Main Results:
- S aureus infections increased, with MRSA rising tenfold (2 to 21 per 1000 admissions).
- Antibiotics treating MRSA increased from 52% to 79%; those treating only methicillin-susceptible S aureus declined.
- Clindamycin use surged from 21% to 63% between 1999 and 2008.
Conclusions:
- Antibiotic prescribing patterns for pediatric S aureus infections have significantly changed.
- The rise of community-associated MRSA has driven shifts towards agents like clindamycin.
- Ongoing surveillance of S aureus susceptibility is essential for effective treatment.
Objectives:
The objective of this study was to describe trends in antibiotic management for Staphylococcus aureus infections among hospitalized children from 1999 to 2008.
Methods:
A retrospective study was conducted by using the Pediatric Health Information Systems database to describe antibiotic treatment of inpatients with S aureus infection at 25 children's hospitals in the United States. Patients who were admitted from 1999 to 2008 with International Classification of Diseases, Ninth Revision, Clinical Modification codes for S aureus infection were included. Trends in the use of vancomycin, clindamycin, linezolid, trimethoprim-sulfamethoxazole, cefazolin, and oxacillin/nafcillin were examined for percentage use and days of therapy per 1000 patient-days.
Results:
A total of 64813 patients had a discharge diagnosis for S aureus infection. The incidence of methicillin-resistant S aureus (MRSA) infections during this period increased 10-fold, from 2 to 21 cases per 1000 admissions, whereas the methicillin-susceptible S aureus infection rate remained stable. Among patients with S aureus infections, antibiotics that treat MRSA increased from 52% to 79% of cases, whereas those that treat only methicillin-susceptible S aureus declined from 66% to <30% of cases. Clindamycin showed the greatest increase, from 21% in 1999 to 63% in 2008. Similar trends were observed by using days of therapy per 1000 patient-days.
Conclusions:
Antibiotic prescribing patterns for the treatment of S aureus infections have changed significantly during the past decade, reflecting the emergence of community-associated MRSA. Clindamycin is now the most commonly prescribed antibiotic for S aureus infections among hospitalized children. The substantial use of clindamycin emphasizes the importance of continuous monitoring of local S aureus susceptibility patterns.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antimicrobial Effectiveness
